Literature DB >> 17048477

The blood-brain barrier and brain drug delivery.

J M Koziara1, P R Lockman, D D Allen, R J Mumper.   

Abstract

The present report encompasses a thorough review of drug delivery to the brain with a particular focus on using drug carriers such as liposomes and nanoparticles. Challenges in brain drug delivery arise from the presence of one of the strictest barriers in vivo-the blood-brain barrier (BBB). This barrier exists at the level of endothelial cells of brain vasculature and its role is to maintain brain homeostasis. To better understand the principles of brain drug delivery, relevant knowledge of the blood-brain barrier anatomy and physiology is briefly reviewed. Several approaches to overcome the BBB have been reviewed including the use of carrier systems. In addition, strategies to enhance brain drug delivery by specific brain targeting are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048477     DOI: 10.1166/jnn.2006.441

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  16 in total

Review 1.  Xenobiotic pulmonary exposure and systemic cardiovascular response via neurological links.

Authors:  Phoebe A Stapleton; Alaeddin B Abukabda; Steven L Hardy; Timothy R Nurkiewicz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 2.  Blood-brain barrier transport of therapeutics via receptor-mediation.

Authors:  Angela R Jones; Eric V Shusta
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

3.  From the liver to the brain across the blood-brain barrier.

Authors:  Vivian I Teichberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

Review 4.  Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents.

Authors:  Raquel F Epand; Amram Mor; Richard M Epand
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

5.  Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase.

Authors:  Hai Yuan; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2007-01-17       Impact factor: 2.823

6.  Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier.

Authors:  Daren Wang; Salim S El-Amouri; Mei Dai; Chia-Yi Kuan; David Y Hui; Roscoe O Brady; Dao Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 7.  Molecular determinants of blood-brain barrier permeation.

Authors:  Werner J Geldenhuys; Afroz S Mohammad; Chris E Adkins; Paul R Lockman
Journal:  Ther Deliv       Date:  2015-08-25

8.  Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.

Authors:  Yi Shu; Dan Shu; Farzin Haque; Peixuan Guo
Journal:  Nat Protoc       Date:  2013-08-01       Impact factor: 13.491

Review 9.  Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.

Authors:  Natalia Vykhodtseva; Nathan McDannold; Kullervo Hynynen
Journal:  Ultrasonics       Date:  2008-04-14       Impact factor: 2.890

10.  "Clicked" sugar-curcumin conjugate: modulator of amyloid-β and tau peptide aggregation at ultralow concentrations.

Authors:  Sukanta Dolai; Wei Shi; Christopher Corbo; Chong Sun; Saadyah Averick; Dinali Obeysekera; Mina Farid; Alejandra Alonso; Probal Banerjee; Krishnaswami Raja
Journal:  ACS Chem Neurosci       Date:  2011-10-13       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.